Omalizumab outperforms oral immunotherapy in treating multi-food allergy

A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than...

Researchers develop mouse model to study neutrophilic asthma

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative...

Growth factor cocktail could reverse deadly effects of anthrax toxin

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But...

Fish oil supplements beat oily fish at reducing harmful blood vesicles

A high-dose fish oil supplement slashed clot-promoting blood vesicles in healthy adults—outperforming oily fish and pointing to EPA...

Scientists engineer promising vaccine target for Lyme disease

Meeting the unmet need for a vaccine is the top priority for researchers studying Lyme disease, which infects...

How your diet and probiotics can improve vaccine effectiveness

Could your gut bacteria decide how well vaccines work? A new study reveals how diet and probiotics could...

CDC confirms black-legged ticks can cause red meat allergy in humans

A woman in Maine developed a dangerous meat allergy after a black-legged tick bite—prompting the CDC to rethink...

Study explores how nanoplastics could affect child’s immune system during pregnancy

Allergies and asthma are widespread diseases that could arise during embryonal development in the womb. A team led...

Fruit fly study reveals key brain proteins that help prevent seizures

One in ten people will have at least one seizure in their life, but effective treatments for seizures...

Race-neutral equation improves asthma diagnosis for Black children

Despite ongoing progress, structural racism and health disparities continue to shape healthcare practices in ways healthcare providers may...

Older adults may have stronger immunity to bird flu, Penn study finds

Prior exposures to specific types of seasonal influenza viruses promote cross-reactive immunity against the H5N1 avian influenza virus,...

Gut bacteria turn bile acids into allies against cancer

Bacteria naturally present in the human intestine, known as the gut microbiota, can transform cholesterol-derived bile acids into...

Asthma and allergy rates higher among First Nations people in Australia

Researchers at The University of Queensland have found First Nations people are twice as likely to present at...

New consensus report aims to improve anaphylaxis treatment worldwide

A groundbreaking consensus report on anaphylaxis – the severe reaction some people experience from bee stings, peanut butter...

Social media and peer pressure fueling dangerous drug misuse

Social media trends and peer pressure can be a dangerous combination to your children and their friends, especially...

Scientists discover key molecular switch for blood stem cell regeneration

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which...

Understanding FDA’s complaint reporting systems

If you have a complaint about a product regulated by the U.S. Food and Drug Administration (FDA), the...

Material from nasal lavage provides a basis for assessing COPD

Early diagnosis of COPD, chronic obstructive pulmonary disease, increases the quality of life of the patient and the...

Study reveals an integrated care model for improving outcomes among people who inject drugs

Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 ("INTEGRA") study at the...

Baked eggs in infancy may lower lifelong egg allergy risk

Feeding babies baked eggs early could prevent egg allergies—new research reveals how timing and exposure shape immune tolerance!...

Asthma and antibiotic use increase the likelihood of revision sinus surgery

The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was not a predictor of revision surgery, according to a new study. The register-based population study explored the probability of revision surgery and factors associated with it in individuals with chronic rhinosinusitis with nasal polyps who had undergone endoscopic sinus surgery.

Nasal polyps are benign mucosal protrusions that can, in severe cases, block the nostrils entirely. Nasal polyps often develop in conjunction with a prolonged sinus infection, leading to chronic rhinosinusitis with nasal polyps.

Chronic rhinosinusitis with nasal polyps is treated with nasally administered corticosteroids and, as the diseases progresses, also with orally administered corticosteroids. If these treatments are insufficient, polyps can be surgically removed via sinus surgery. After the procedure, chronic rhinosinusitis with nasal polyps is generally manageable, but a small percentage of patients require revision surgery due to symptom recurrence and polyp regrowth.

The study included data on all Finnish adults with chronic rhinosinusitis with nasal polyps who underwent endoscopic sinus surgery between January 2012 and December 2018, comprising a total of 3,506 individuals. The patients' ages ranged from 42 to 65 years, with 72% being male. The follow-up continued until the end of 2019.

During the follow-up, 15.9% of patients required at least one revision surgery. The probability of revision sinus surgery including the removal of nasal polyps increased if the patient had asthma or was on antibiotics at the time of their initial surgery. When the average patient was defined as a 55-year-old male, the probability of revision surgery within three years was 11% without asthma or antibiotic use, increasing to 16% with either asthma or antibiotic use, and to 23% with both.

Revision surgeries were more common among younger patients. The more extensive the initial surgery, the higher the probability of revision surgery. Patients who had frequently required oral corticosteroids before their initial surgery were also more likely to undergo repeated revision surgeries.

The results indicate that severe chronic rhinosinusitis with nasal polyps is often associated with asthma. Patients with a severe form of the disease may benefit from additional treatments, such as biologics, if the disease cannot be managed despite repeated courses of antibiotics, oral corticosteroids, and sinus surgeries."

Professor Sanna Toppila-Salmi, University of Eastern Finland, lead author of the study

The study suggests that a patient's asthma status and the number of antibiotic and oral corticosteroid courses should be considered when contemplating surgery.

"Patients should also be informed of the fact that the severe form of the disease may recur post-surgery, and this needs to be done before any decision on surgery is made," Professor Salmi adds.

The study was published in Clinical and Translational Allergy and conducted in collaboration with the pharmaceutical company AstraZeneca, the research service company Medaffcon, and Tampere University.

Source:

University of Eastern Finland (UEF Viestintä)

Journal reference:

Toppila-Salmi, S., et al. (2025). Predictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps. Clinical and Translational Allergy. doi.org/10.1002/clt2.70032.


Source: http://www.news-medical.net/news/20250204/Asthma-and-antibiotic-use-increase-the-likelihood-of-revision-sinus-surgery.aspx

Inline Feedbacks
View all comments
guest